These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6848204

  • 1. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL, Coon JS, Ward RM, Falor WH, Miller AW, Weinstein RS.
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [Abstract] [Full Text] [Related]

  • 2. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H, Yamada H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y.
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [Abstract] [Full Text] [Related]

  • 3. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H.
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [Abstract] [Full Text] [Related]

  • 4. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y, Satoh T.
    Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR.
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [Abstract] [Full Text] [Related]

  • 7. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS, Miller AW, Coon JS.
    Prog Clin Biol Res; 1984 Feb; 153():249-60. PubMed ID: 6382282
    [No Abstract] [Full Text] [Related]

  • 8. [The study on Thomsen-Friedenreich antigen in bladder tumor].
    Oda Y.
    Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
    [Abstract] [Full Text] [Related]

  • 9. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M.
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E, Gutiérrez-Hoyos A, Garrido C, Arozena F.
    Arch Esp Urol; 1991 Nov; 44(1):47-52. PubMed ID: 2064423
    [Abstract] [Full Text] [Related]

  • 11. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y, Kumon H, Matsumura Y, Ohmori H.
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract] [Full Text] [Related]

  • 12. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M, Tichá V, Jansa P, Student V, Vanák J.
    Acta Univ Palacki Olomuc Fac Med; 1991 Sep; 130():157-62. PubMed ID: 1838863
    [Abstract] [Full Text] [Related]

  • 13. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N.
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [Abstract] [Full Text] [Related]

  • 14. Immunology of the bladder.
    Graham SD.
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [Abstract] [Full Text] [Related]

  • 15. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T, Fukui I, Yokogawa M, Oshima H.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract] [Full Text] [Related]

  • 16. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 17. [The usefulness of the carbohydrate antigen CA-50 in the prognosis of transitional-cell bladder carcinomas].
    Moreno Sierra J, Blanco Jímenez E, Silmi Moyano A, Ortega Heredia MD, Páramo González P, Maestro de las Casas ML, Fernández Lucas C, Ramírez Fernández JC, Luengo Alpuente S, Gómez Vegas A.
    Arch Esp Urol; 1993 Nov; 46(9):775-8. PubMed ID: 8304791
    [Abstract] [Full Text] [Related]

  • 18. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 19. Cellular fibronectin in patients with transitional cell carcinoma of the bladder.
    Hegele A, Heidenreich A, Varga Z, von Knobloch R, Olbert P, Kropf J, Hofmann R.
    Urol Res; 2003 Feb; 30(6):363-6. PubMed ID: 12599015
    [Abstract] [Full Text] [Related]

  • 20. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.